Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 5
2006 4
2007 1
2008 1
2009 4
2010 9
2011 8
2012 12
2013 10
2014 18
2015 22
2016 12
2017 11
2018 9
2019 11
2020 9
2021 16
2022 13
2023 18
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean chen chun lin (232 results)?
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
Tsuboi M, Herbst RS, John T, Kato T, Majem M, Grohé C, Wang J, Goldman JW, Lu S, Su WC, de Marinis F, Shepherd FA, Lee KH, Le NT, Dechaphunkul A, Kowalski D, Poole L, Bolanos A, Rukazenkov Y, Wu YL; ADAURA Investigators. Tsuboi M, et al. N Engl J Med. 2023 Jul 13;389(2):137-147. doi: 10.1056/NEJMoa2304594. Epub 2023 Jun 4. N Engl J Med. 2023. PMID: 37272535 Clinical Trial.
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.
Heymach JV, Harpole D, Mitsudomi T, Taube JM, Galffy G, Hochmair M, Winder T, Zukov R, Garbaos G, Gao S, Kuroda H, Ostoros G, Tran TV, You J, Lee KY, Antonuzzo L, Papai-Szekely Z, Akamatsu H, Biswas B, Spira A, Crawford J, Le HT, Aperghis M, Doherty GJ, Mann H, Fouad TM, Reck M; AEGEAN Investigators. Heymach JV, et al. N Engl J Med. 2023 Nov 2;389(18):1672-1684. doi: 10.1056/NEJMoa2304875. Epub 2023 Oct 23. N Engl J Med. 2023. PMID: 37870974 Clinical Trial.
First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion-Positive NSCLC.
Zhou C, Solomon B, Loong HH, Park K, Pérol M, Arriola E, Novello S, Han B, Zhou J, Ardizzoni A, Mak MP, Santini FC, Elamin YY, Drilon A, Wolf J, Payakachat N, Uh MK, Rajakumar D, Han H, Puri T, Soldatenkova V, Lin AB, Lin BK, Goto K; LIBRETTO-431 Trial Investigators. Zhou C, et al. N Engl J Med. 2023 Nov 16;389(20):1839-1850. doi: 10.1056/NEJMoa2309457. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870973 Clinical Trial.
Advances in Quantum-Dot-Based Displays.
Huang YM, Singh KJ, Liu AC, Lin CC, Chen Z, Wang K, Lin Y, Liu Z, Wu T, Kuo HC. Huang YM, et al. Among authors: lin cc. Nanomaterials (Basel). 2020 Jul 6;10(7):1327. doi: 10.3390/nano10071327. Nanomaterials (Basel). 2020. PMID: 32640754 Free PMC article. Review.
The emerging landscape of salivary diagnostics.
Zhang Y, Sun J, Lin CC, Abemayor E, Wang MB, Wong DT. Zhang Y, et al. Among authors: lin cc. Periodontol 2000. 2016 Feb;70(1):38-52. doi: 10.1111/prd.12099. Periodontol 2000. 2016. PMID: 26662481 Review.
Liquid biopsy genotyping in lung cancer: ready for clinical utility?
Huang WL, Chen YL, Yang SC, Ho CL, Wei F, Wong DT, Su WC, Lin CC. Huang WL, et al. Among authors: lin cc. Oncotarget. 2017 Mar 14;8(11):18590-18608. doi: 10.18632/oncotarget.14613. Oncotarget. 2017. PMID: 28099915 Free PMC article. Review.
183 results